International partnership is an important tool for strengthening health systems & advancing cancer research & control, but is often characterized by power & resource inequities. Read a new editorial by Linsey Eldridge Satish Gopal, MD, MPH TAO Ophira Ginsburg 👇 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Want to learn more about the Hematology-Oncology Fellowship Program WashU Heme/Onc Fellowship at Test Account? See our video below. WashU Hematology Sana Saif Ur Rehman Neha Mehta-Shah Stephen Oh WUSM Department of Medicine Abby Spencer, MD, MS, FACP #MedEd Hem-Onc Fellows Network m.youtube.com/watch?v=M6ehgH…

Thanks Nature Medicine for allowing me to share why National Cancer Institute NCI Center for Global Health believes reignited #cancermoonshot requires #globalhealth #CancerResearch commitments in #LMICs where most 🌍 cancer burden is increasingly concentrated. nature.com/articles/s4159…

**HIV Hodgkin therapy ✅Brentuximab vedotin–AVD was highly active and had a tolerable adverse event rate in HIV-cHL ✅The complete reponse rate is encouraging From Lee Ratner WashUOncology and colleagues #nhlsm #lymsm WUSM Department of Medicine Test Account Siteman Cancer Center thelancet.com/journals/lanha…

📣Saturday, September  2  @ 4 PM EST on MedNewsWeek!🎙️ We are excited to be hosting Global Leader & Keynote Speaker, 🌟Dr. Kathryn Lurain🌟– Clinical Director, HIV and AIDS Malignancy Branch at the NCI– as she discusses the latest in HIV 🦠 associated cancers 🦀.

NEW on our blog from guest contributor Beryne Odeny MD MPH PhD and Exec Ed Julia Robinson: Redefining the Practice of Global Health: Insights from the Consortium of Universities for Global Health (CUGH) 2023 conference speakingofmedicine.plos.org/2023/09/19/red…

In Blood Advances Rasmussen et al. highlight differences in progression free survival in KSHV/HHV8 associated multicentric Castleman disease by HIV status - despite uniform treatment, risk of progression is higher in HIV neg patients as compared with PWH. ashpublications.org/bloodadvances/…

Thomas Uldrick, MD and I explore these findings further in our editorial #HIVOnc ashpublications.org/bloodadvances/…

Tishiya Carey, former postbac fellow in the HIV and AIDS Malignancy Branch, presenting her work on survival outcomes in older people living with HIV and cancer. Ramya Ramaswami Kate Lurain #AACRdisp23

This is a lose lose situation. Terrible for science, terrible for the affected colleagues from lower-income countries, as well as for us researchers from high-income countries who miss out on their insights and on potential collaborations.

Reviving my account to express immense gratitude to the Winn Awards for the opportunity to join the Robert A Winn Diversity in Clinical Trials program - wrapping up the week I am reenergized and so thankful for the connection with new mentors, friends, and collaborators 😊😊😊

Honored to be part of the Winn CDA program, dedicated to promoting diversity in cancer clinical trials. 🌍 #WinnCDA #ClinicalTrials #DiversityinResearch #HIVOnc #GlobalOncology WashUOncology KESHO

In our latest Aligned blog, we spoke with Ramya Ramaswami, M.B.B.S., M.P.H., Lasker Clinical Research Scholar in the HIV and AIDS Malignancy Branch, about her career, immigrating to the U.S. and the role resilience has played in her success. ▶️ go.cancer.gov/OQlSXli

Gilead is proud to be a funding partner of The Robert A. Winn Diversity in Clinical Trials Award Program, designed to train early-stage investigator physicians and address the longstanding lack of diversity in clinical trials. Learn more: gilead.inc/3uHKj9h

Delighted that our paper on impact of bintrafusp alfa in NSCLC is out. Have some very long ongoing CR which limited our ability for post biopsies. Check it out 👉 jitc.bmj.com/content/12/3/e…

Only a couple of hours left to the #KICC2024 Abstract Submission deadline. This is your reminder to grab this golden opportunity and contribute to the #cancertreatment revolution in Africa! Submit now 🌟 bit.ly/3WTrEmB Abeid Athman (Omar). Ministry of Health National Cancer Institute of Kenya Kenya Hospices and Palliative Care Association

#KICC2024 Faculty Development Workshop in partnership with AORTIC Immerse yourself in a transformative journey of academic empowerment with our exclusive pre-conference workshop focused on faculty development. Tailored for #educators, #researchers & aspiring academic

Dr Kawango Agot, Rest in Power. A force for good in Kenya, a mentor of bright minds, a kind soul, and role model for many researchers. IDRO tribute: impact-rdo.org/tribute-to-kaw… crowdfunding site to support her family: gofund.me/1811c49f ⁦Harsha Thirumurthy⁩ ⁦University of Washington⁩ @avac

There is an increased risk of cancer among people with HIV globally. Check out this new publication by TAO that sheds light on the crucial intersection of oncology and HIV research, and offers new insights for clinical practice. WashU Medicine sciencedirect.com/science/articl…